CD96 and bladder transitional cell carcinoma: Immunohistochemical staining of 34 BLCA samples collected from the local hospital revealed that cases with advanced TNM stages had lower levels of CD96 and OAS1, and higher levels of CSH1 (all P < 0.05, Fig. 4E).